169261 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of colon
Polynucleotides encoding signal peptide-containing molecules
#902ALDH1 As A Cancer Stem Cell Marker
#903MARKs as Modifiers of the p53 Pathway and Methods of Use
#904CANCER ASSOCIATED PROTEIN PHOSPATASES AND THEIR USES
#905Use of C3a and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#906DETECTING THE PRESENCE OF PYRUVATE KINASE ISOENZYME IN FECES
#907Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
#908Novel human genes and gene expression products: II
#909Antibodies That Specifically Bind PMS2
#910Tif1-Beta Peptides and Nucleic Acids for Diagnosis and Therapy of Cancer and Colorectal Cancerous Disorders
#911Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity
#912SCDs As Modifiers of the p53 Pathway and Methods of Use
#913Polypeptide useful for cancer diagnosis and treatment
#914Human Ron-related gene variant associated with cancers
#915Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1)
#916Method for diagnosing colon cancer
#917Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor
#918Methods for making cancer prognoses based on subcellular localization of biomarkers
#919BIOMARKERS FOR USE IN THE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER
#920CYFRA 21-1 as a marker for colorectal cancer
#92136P6D5: secreted tumor antigen
#922Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23
#923Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
#924Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
#925Identification of Phospholipase A2 as Target in Cancer Treatment, with Special Emphasis on Colorectal Cancer and Its Mechanism of Action
#926Antibodies That Immunospecifically Bind to TRAIL Receptors
#927Protein kinase C iota
#928Diagnostic methods for determining treatment
#929Treatment and Assays
#930PRO1477 polypeptides
#931Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)
#932Diagnostic and therapeutic agents
#933Interaction of Colon Cancer Related Gene C200RF20 With P120
#934Clinical algorithm for excluding patients identified in virtual imaging
#935NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER AND USES THEREOF
#936PRO4356 polypeptides
#937Methods for diagnosing and treating kidney and colorectal cancer
#938Use of protein PSA3 as a marker for colorectal cancer
#939Proteins
#940Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
#941Methods and compounds for lymphoma cell detection and isolation
#942Reagents and methods for cancer prognosis and pathological staging
#943Method of examining colon cancer and colon adenoma
#944Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#945Protein RS15A as a marker for colorectal cancer
#946Metastatic breast and colon cancer regulated genes
#947Methods for determining the prognosis for cancer patients using TUCAN
#948Colon Specific Gene and Protein and Cancer
#949Method for diagnosing selected adenocarcinomas
#950Antibodies as a cancer diagnostic
#951Protein CBP2 as a marker for colorectal cancer
#952HPRP4s modifiers of the p53 pathway and methods of use
#953Analytical method for detecting alkaline sphingomyelinase and kit for use in such method
#954Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
#955Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
#956Assays and methods using biomarkers
#957Assays and methods using biomarkers
#958Method for diagnosing colon cancer
#959Method for detection of colorectal cancer in human samples
#960PRO1298 polypeptides
#961Treatment of metastatic colon cancer with b-subunit of shiga toxin
#962Novel compositions and methods in cancer
#963Mammalian IAP gene family, primers, probes and detection methods
#96426199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
#965Methods and compositions for treating diseases targeting MABA1
#966Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer
#967Marks as modifers of the PTEN pathway and methods of use
#968Cytotoxicity mediation of cells evidencing surface expression of CD44
#969Mammalian IAP gene family, primers, probes and detection methods
#970Mammalian IAP gene family, primers, probes and detection methods
#971Quantitative assays for PDGFR-beta in body fluids
#972Socs-3 promoter methylation in cancer
#973Prostate cancer diagnosis and treatment
#974Mammalian IAP gene family, primers, probes and detection methods
#975Mammalian IAP gene family, primers, probes and detection methods
#976Immunoassays to detect diseases or disease susceptibility traits
#977Cancerous disease modifying antibodies
#978Cancerous disease modifying antibodies
#979Cancerous disease modifying antibodies
#980Mammalian IAP gene family, primers, probes and detection methods
#981Mammalian IAP gene family, primers, probes and detection methods
#982Mammalian IAP gene family, primers, probes and detection methods
#983Materials and methods for colorectal cancer screening, diagnosis and therapy
#984Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#985Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
#986Mrp3 genes and uses thereof
#987Mammalian IAP gene family, primers, probes, and detection methods
#98814094, a novel human trypsin family member and uses thereof
#989Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
#990Methods for the identification, assessment, and treatment of patients with cancer therapy
#991Method of diagnosing colon and gastric cancers
#992Transmembrane protein differentially expressed in cancer
#993Method of diagnosing colorectal adenomas and cancer using infrared spectroscopy
#994Compositions, splice variants and methods relating to colon specific genes and proteins
#995Compositions, splice variants and methods relating to colon specific gene and proteins
#996Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
#997Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples
#998Secreted and transmembrane polypeptides and nucleic acids encoding the same
#999Monoclonal antibody and hybridoma producing the same
#1000Sphks as modifiers of the p53 pathway and methods of use
#1001Cancer antigens and utilization thereof
#1002Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1003Secreted and transmembrane polypeptides and nucleic acids encoding the same
#10047a5/prognostin and use thereof for the diagnostic and therapy of tumors
#1005Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4
#1006Peptide-chelate conjugates
#1007Method of detecting colon cancer marker
#1008Novel compositions and methods for cancer
#1009Method for treating or preventing metastasis of colorectal cancers
#1010Mammalian IAP gene family, primers, probes and detection methods
#1011Use of protein PSE3 as a marker for colorectal cancer
#1012Use of protein RLA-0 as a marker for colorectal cancer
#1013Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1014Compositions and methods for the therapy and diagnosis of colon cancer
#1015Use of protein spee as a marker for colorectal cancer
#1016Use of protein PLST as a marker for colorectal cancer
#1017Mitochondrial stress-70 protein markers for colorectal cancer
#1018Nucleic acid sequences differentially expressed in cancer tissue
#1019Use of PRN3/ILEU as a marker for colorectal cancer
#1020Antibody and use thereof
#1021Anti-pro1477 antibodies
#1022Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
#1023Use of specified tcf target genes to identify drugs for the treatment of cancer in particular colorectal cancer in which tcf/ss-cateini/wnt signalling plays a central role
#1024LIMKs as modifiers of p53 pathway and methods of use
#1025Method for detecting loss of wild-type p53
#1026Composition splice variants and methods relating to cancer specific genes and proteins
#1027Tumor marker and its use
#1028Amplified and overexpressed gene in colorectal cancers
#1029Analytical method for detecting alkaline sphingomyelinase and kit for use in such method
#1030Targeted delivery to legumain-expressing cells
#1031Methods for treating patients and identifying therapeutics
#1032Differential expression of genes in microsatellite instability
#1033Mammalian IAP gene family, primers, probes, and detection methods
#1034Method for assessing metastatic properties of breast cancer
#1035Insulin-like growth factor system and cancer
#1036Use of protein MASP as a marker for colorectal cancer
#1037Method for treating or preventing metastasis of colorectal cancers
#1038Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase
#1039Cancer-linked gene as target for chemotherapy
#1040Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer
#1041Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
#1042PRO16090 antibodies
#1043Oxaliplatin anti-resistance agent
#1044Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
#1045Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods, and kits thereof
#1046Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1047PRO19624 antibodies
#1048PRO9835 antibodies
#1049Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1050Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1051Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1052Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1053Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1054Colon tumor specific binding peptides
#1055Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
#1056Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1057Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1058Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1059Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1060Methods and compositions for categorizing patients
#1061Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1062Serpentine transmembrane antigens expressed in human cancers and uses thereof
#1063Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1064Genes and polypeptides relating to hepatocellular or colorectal carcinoma
#1065Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
#1066Human Mob-5 (IL-24) receptors and uses thereof
#1067Antibodies that specifically bind PMS2
#1068Nicotinamide N-methyltransferase as a marker for colorectal cancer
#1069Methods of screening for cell proliferation or neoplastic disorders
#1070Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1071Cancer associated protein phosphatases and their uses
#1072Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1073Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
#1074Reagents and methods useful for detecting diseases of the gastrointestinal tract
#1075Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1076Compositions and methods for diagnosing, preventing, and treating cancers
#1077Analysis of apoptotic bodies in bodily fluids
#1078Methods for detecting nucleic acids indicative of cancer
#1079Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1080Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1081Ephrin-B receptor protein involved in carcinoma
#1082Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
#1083Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1084Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
#1085Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1086Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
#1087Neopeptides and methods useful for detection and treatment of cancer
#1088Methods and compositions for categorizing patients
#1089Antibody against illfdyfnr
#1090Identification of cancer protein biomarkers using proteomic techniques
#1091Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1092Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
#1093Detection of CDX2 expression
#1094HADHs as modifiers of the p21 pathway and methods of use
#1095HADHs as modifiers of the p21 pathway and methods of use
#1096Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1097Early detection of cancer of specific type using 1HNMR metabonomics
#1098Chds as modifiers of the p53 pathway and methods of use
#1099Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#1100Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1101Sumo inhibitors
#1102Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
#1103Signal peptide-containing molecules
#1104Method of diagnosing, monitoring, staging, imaging and treating colon cancer
#1105HX2004-6 polypeptide expressed in cancerous cells
#1106Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
#1107Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
#1108Methods for diagnosis and treatment of epithelial-derived cancers
#1109Noninvasive screening method for the detection of colorectal cancer
#1110Methods for diagnosis and treatment of epithelial-derived cancers
#1111Analytical method for detecting alkaline sphingomyelinase and kit for use in such method
#1112Dgks as modifiers of the p53 pathwha and methods of use
#1113Methods and compositions for detecting colon cancers
#1114Method of diagnosing, monitoring, staging, imaging and treating colon cancer
#1115Cytotoxicity mediation of cells evidencing surface expression of CD44
#1116Detection and treatment of cancers of the colon
#1117Antibodies specific for phosphorylation sites and screening methods using the same antibodies
#1118Metastatic colorectal cancer signatures
#1119JAB1 as a prognostic marker and a therapeutic target for human cancer
#1120Determining prognosis of colon or breast cancer by measuring TTK expression
#1121Detection of colon or breast cancer by measuring TTK polypeptide expression
#1122Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#1123Detection of colon or breast cancer by measuring TTK polynucleotide expression
#1124Phosphospecific PAK antibodies and diagnostic kits
#1125Compositions, splice variants and methods relating to colon specific genes and proteins
#1126Laminin chains: diagnostic and therapeutic use
#1127Viral sequences
#1128METHOD OF DETERMINING WHETHER A PATIENT AFFLICTED WITH CANCER CAN BE TREATED BY A THERAPEUTIC AGENT THAT TARGETS THE 17-1A ANTIGEN
#1129Cancerous disease modifying antibodies
#1130Gene amplification and overexpression in cancer
#1131Novel optical method for diagnosis and staging of premalignant and malignant human colonic tissues
#1132Cytotoxicity mediation of cells evidencing surface expression of CD44
#1133Serpentine transmembrane antigens expressed in human cancers and uses thereof
#1134Targets for controlling cellular growth and for diagnostic methods
#1135Method and system for automated population outreach
#1136Method and system for automated population outreach
#1137Monoclonal antibody to human line-1 ORF2 protein and method for early detection of transforming cells in pre-neoplastic tissues of a human subject